Labcorp Holdings Inc. LH

309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Labcorp Holdings Inc. (LH) Operating margin

Labcorp Holdings Inc.'s operating margin over the twelve months to 30 June 2026 was 10.4%, up 0.5 percentage points from fiscal 2025 (9.92%). Over the past ten years it has ranged from 5.97% (fiscal 2023) to 23.2% (fiscal 2021); the current reading is higher than 27% of that period. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 9.92% 1.57
FY2024 8.35% 2.38
FY2023 5.97% (6.14)
FY2022 12.1% (11.10)
FY2021 23.2% 5.72
FY2020 17.5% 5.98
FY2019 11.5% (0.19)
FY2018 11.7% (0.96)
FY2017 12.7% (0.64)
FY2016 13.3% 1.82

Quarterly

Period Operating margin Change (points)
Jun 2026 12.1% 1.34
Mar 2026 10.8% 3.15
Dec 2025 7.61% (3.52)
Sep 2025 11.1% (0.05)
42 more quarters

Against its own ten years

Low 5.97% High 23.2%
Ten-year median 11.7%
Current reading's percentile 27

Operating margin against peers

Company Operating margin
MTD Mettler-Toledo International, Inc. compare 28.4%
MEDP Medpace Holdings, Inc. compare 21.0%
DGX Quest Diagnostics Incorporated compare 14.1%
RVTY Revvity Inc. compare 12.3%
LH Labcorp Holdings Inc. 10.4%
ICLR ICON PLC compare 3.57%
CRL Charles River Laboratories International, Inc. compare 2.25%
TWST Twist Bioscience Corporation compare −33.6%
GH Guardant Health, Inc. compare −39.8%
Diagnostics & Research industry median −8.57%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on LH